Pieter Rottiers

Director Ejecutivo en Intrexon ActoBiotics NV .

Consumer Services

Health Technology

Cargos activos de Pieter Rottiers

Empresas	Cargo	Inicio	Fin
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Director/Miembro de la Junta	-	-
	Director Ejecutivo	-	-
	Director Técnico/Científico/I+D	09/10/2013	-
	Corporate Officer/Principal	21/08/2009	09/10/2013

Empresas	Cargo	Inicio	Fin
Vlaams Instituut voor Biotechnologie - Flanders Institute Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.	Corporate Officer/Principal	01/01/2006	01/01/2006

Ghent University

Doctorate Degree

Internacional

Bélgica

Operativa

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Sectorial

Consumer Services	3
Health Technology	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Health Technology

Empresas privadas

Health Technology